Supreme Court weighs in on Pur­due Phar­ma's bank­rupt­cy, with an eye to­ward opi­oid vic­tims

WASH­ING­TON — The no­to­ri­ous fam­i­ly at the cen­ter of the US opi­oid epi­dem­ic — the Sack­lers — may not have been one of the par­ties in to­day’s case be­fore the Supreme Court, but they were fea­tured promi­nent­ly in the oral ar­gu­ments.

Jus­tices fo­cused their ques­tions on whether the bil­lion­aire fam­i­ly known for Pur­due Phar­ma’s Oxy­Con­tin has put up enough mon­ey for opi­oid vic­tims, and whether the com­pa­ny’s set­tle­ment and im­mu­ni­ty from fu­ture suits are jus­ti­fied.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER